Clinical Evaluation of High Viscosity Glass Ionomer Strip Crowns in Primary Maxillary Incisors
Launched by HACETTEPE UNIVERSITY · Apr 28, 2023
Trial Information
Current as of September 22, 2025
Unknown status
Keywords
ClinConnect Summary
Following the decision on the appropriate size of celluloid strip crown, the tooth will be isolated using roll cottons and the "cavity conditioner" (GC, Japan) will be applied to all surfaces for 10 seconds, washed away and dried with cotton pellets. The selected celluloid strip crown will be filled with a fluoride-releasing bulk fill hybrid glass ionomer cement (EQUIA Forte, GC, Japan) prepared by mixing for 10 seconds in an automatic mixer and placed on the tooth with light pressure. The excess material on the crown margins will be removed with a hand instrument, and the celluloid strip c...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Read the informed consent form and agree to participate in the study
- • Healthy children, aged 2-6 years
- • Presenting at least one primary anterior tooth with a class I, II, IV or V caries lesion
- Exclusion Criteria:
- • Uncooperative children
- • The need for vital or non-vital endodontic treatment in the primary tooth to be treated
- • Previously restorated tooth
- • Presence of bruxism, Class III occlusion or deep bite
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, Turkey
Ankara, Altındağ, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported